D-0078-2018 Class III Terminated
FDA drug recall D-0078-2018 was initiated by Allergan Sales, LLC on October 19, 2017 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications. The recall status is terminated (terminated October 30, 2019). Affected quantity: 153,616 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- November 22, 2017
- Initiation Date
- October 19, 2017
- Termination Date
- October 30, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 153,616 bottles
Product Description
Lumigan (bimatoprost ophthalmic solution) 0.01%, 2.5 mL bottle, Rx only, Allergan, Irvine, CA 92612. NDC# 0023-3205-03
Reason for Recall
Failed Impurities/Degradation Specifications.
Distribution Pattern
Nationwide and Barbados, Curacao, Dominican Republic, Guyana, Jamaica, and Trinidad and Tobago.
Code Information
Lot #: 92575 Exp. JUN-2018